Seeking Alpha

Novavax <> could win the regulatory nod for its COVID-19 shot even without the authorizations from the U.S. and…

Popular Inc’s provision expense will likely remain subdued in the second half of the year. Read more to know…

Neurocrine posted better than expected sales in the second quarter, with a much-needed beat for Ingrezza sales, but the…

TPB Acquisition priced its 17.5M units IPO at $10/unit; units are expected to commence trading on Nasdaq Capital Market under…

With stretched U.S. market valuations, VWO offers investors a diversified option to participate in some of the world’s fastest…

Olympic reported exceptional sales growth as machinery customers and other industrial companies scramble to fill swelling order…

After recent developments, Morgan Stanley analysts led by Matthew Harrison have reshuffled their ratings and price targets on…

Digital Turbine reported blockbuster Q1 2022 results. See why we think the market is significantly discounting the secular growth…

Cara Therapeutics becomes instantly undervalued if KORSUVA approval goes through on August 23rd. Click here to know my assumptions…